Corvus Pharmaceuticals Inc buy Cantor Fitzgerald
Start price
07.09.23
/
50%
€1.51
Target price
07.09.24
€3.74
Performance (%)
146.36%
End price
08.09.24
€3.72
Summary
This prediction ended on 08.09.24 with a price of €3.72. The BUY prediction by Cantor_Fitzgerald for Corvus Pharmaceuticals Inc saw massive gains of 146.36%. Cantor_Fitzgerald has a follow-up prediction for Corvus Pharmaceuticals Inc where he still thinks Corvus Pharmaceuticals Inc is a Buy. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Corvus Pharmaceuticals Inc | -2.162% | -2.162% | 253.516% |
| iShares Core DAX® | -1.471% | 1.895% | 25.178% |
| iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% |
| iShares Nikkei 225® | -2.115% | 2.450% | 20.561% |
| iShares S&P 500 | 0.394% | 3.118% | 29.456% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Corvus Pharmaceuticals Inc diskutieren
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $4.00 price target on the stock.
Ratings data for CRVS provided by MarketBeat
In the thread Trading Corvus Pharmaceuticals Inc
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Current prediction by Cantor_Fitzgerald for Corvus Pharmaceuticals Inc
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€1.67
01.04.24
01.04.24
-
01.04.25
01.04.25
186.14%
03.10.24
03.10.24
